The German mRCC Registry – aims and results after the first 1000 patients. 2. Juni 2013 Goebell, P.J., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Vogt, M., Marschner, N., 2013. Eur Urol Suppl 2013;12;e1106 DOI:10.1016/S1569-9056(13)61581-X Abstract Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. Fontein, D.B.Y., Seynaeve, C., Hadji, P., Hille, E.T.M., van de Water, W., Putter, H., Kranenbarg, E.M.-K., Hasenburg, A., Paridaens, R.J., Vannetzel, J.-M., Markopoulos, C., Hozumi,… Weiterlesen Effectiveness of sequential treatment of advanced or metastatic renal cell carcinoma (mRCC). Outcome data from the clinical RCC Registry. Goebell, P.J., Müller, L., Lück, A., Overkamp, F., Vogt, M., Marschner, N., 2013. Onkologie 36 (suppl. 7)(V40), 8. doi:10.1159/000356365 Abstract… Weiterlesen